Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1998
11/26/1998WO1998053079A1 Ubiquitin conjugation proteins
11/26/1998WO1998053066A1 Smad2 phosphorylation and interaction with smad4
11/26/1998WO1998052898A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/26/1998WO1998052616A2 Nonsteroidal antirheumatic agents or thrombocyte-agglutination inhibitors to improve representation of vessels, lymph nodes and bone marrow with pharmaceutical preparations containing particles, vesicles of polymers
11/26/1998WO1998052606A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998WO1998052600A1 Methods of enhancing functioning of the upper gastrointestinal tract
11/26/1998WO1998052599A1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
11/26/1998WO1998052593A1 Method for assisting in differential diagnosis and treatment of autistic syndromes
11/26/1998WO1998052585A1 Immunomodulating, bile-derivable compositions for the treatment of viral disorders
11/26/1998WO1998052582A2 Non-myeloablative tolerogenic treatment
11/26/1998WO1998052580A1 Treating asthma by preventing and/or accommodating for s-nitrosothiol breakdown
11/26/1998WO1998052579A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998WO1998052577A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998WO1998052571A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998WO1998052570A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998WO1998052569A1 Combination therapy for modulating the human sexual response
11/26/1998WO1998052565A1 Substance dependence treatment using opiate antagonists and serotonin compounds
11/26/1998WO1998052560A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
11/26/1998WO1998052553A1 Methods for treatment of conditions associated with lactosylceramide
11/26/1998WO1998052545A1 Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
11/26/1998WO1998052540A1 Pharmaceutical compositions
11/26/1998WO1998052415A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998WO1998036776A3 Gel delivery vehicles for anticellular proliferative agents
11/26/1998WO1998036733A3 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/26/1998WO1998035655A3 Method for separating active substances in solid pharmaceutical preparations
11/26/1998WO1998035554A3 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/26/1998WO1998031800A3 Human proteins
11/26/1998DE19750422C1 Use of esters of phyto-sterols
11/26/1998DE19721947A1 Nichtsteroidale Antirheumatika oder Thrombozytenaggregationshemmer zur Verbesserung der Gefäß-, Lymphknoten- und Knochenmarkdarstellung mit pharmazeutischen Zubereitungen, die Partikel, Vesikel oder Polymere enthalten Include NSAIDs, platelet aggregation inhibitors to improve vascular, lymph node and bone marrow representation of pharmaceutical preparations containing particles, vesicles or polymers
11/26/1998CA2291156A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998CA2290818A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/26/1998CA2290788A1 Substance dependence treatment using opiate antagonists and serotonin compounds
11/26/1998CA2290769A1 Ubiquitin conjugation proteins
11/26/1998CA2290598A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998CA2290556A1 Method for assisting in differential diagnosis and treatment of autistic syndromes
11/26/1998CA2290546A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998CA2290459A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
11/26/1998CA2290381A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
11/26/1998CA2290367A1 Non-myeloablative tolerogenic treatment
11/26/1998CA2289906A1 Smad2 phosphorylation and interaction with smad4
11/26/1998CA2289655A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2289654A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2261681A1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
11/25/1998EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production
11/25/1998EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998EP0879879A2 Polypeptide deformylase 1 (Def1)
11/25/1998EP0879820A1 Benzamide analogues, useful as PARP (ADP-Ribosyltransferase, ADPRT) DNA repair enzyme inhibitors
11/25/1998EP0879601A2 Ophthalmic drug delivery system
11/25/1998EP0879596A2 Use of cholinesterase inhibitors to reduce benzodiazepine side effects
11/25/1998EP0879240A1 Human criptin growth factor
11/25/1998EP0879061A2 Spermatogenesis control
11/25/1998EP0879056A1 MODULATION OF TH1/TH2 CYTOKINE EXPRESSION BY RIBAVIRIN$m(3) AND RIBAVIRIN$m(3) ANALOGS IN ACTIVATED T-LYMPHOCYTES
11/25/1998EP0879053A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
11/25/1998EP0879035A1 Bismuth-containing compounds in topical dosage forms
11/25/1998EP0833636A4 Method for inhibiting neoplastic disease in mammals
11/25/1998EP0695189B1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors
11/25/1998EP0633789B1 Wound dressing, wound plaster or carrier matrix
11/24/1998US5840921 Method for the preparation of aldol product 7B
11/24/1998US5840871 Pure polynucleotide sequence as hybridization probes complementary to the polynucleotide; transformed cell cultures yield protein; possible anticancer agents for breast and cell cancer
11/24/1998US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
11/24/1998US5840759 Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
11/24/1998US5840756 Pharmaceutical composition of L-DOPA ester
11/24/1998US5840736 Methods and compositions for stimulating neurite growth
11/24/1998US5840731 Pain-alleviating drug composition and method for alleviating pain
11/24/1998US5840719 Apoptosis inhibitors for treating neurodegenerative diseases
11/24/1998US5840711 Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
11/24/1998US5840705 α-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
11/24/1998US5840701 Antiischemic agents and macomolecules
11/24/1998US5840673 Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors
11/24/1998US5840569 Human GTP-binding proteins
11/24/1998US5840544 DNA encoding rantes homolog from prostate
11/24/1998US5840538 Lgt
11/24/1998US5840535 DNA encoding a zinc ring protein
11/24/1998US5840505 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells
11/24/1998US5840495 Methods for diagnosis of conditions associated with elevated levels of telomerase activity
11/24/1998US5840493 Diagnosis of late onset diabetes by detection of mutations in adenosine triphosphate synthase or transfer rna (lys) genes in a biological sample; labelled nucleotide sequences as detectors; accuracy
11/24/1998US5840301 Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
11/24/1998US5840294 Method for treating amyloidosis
11/24/1998CA2088579C Agents that bind to vcam-1 and uses thereof
11/24/1998CA2007181C Sustained release pharmaceutical composition
11/23/1998CA2232810A1 Novel compounds
11/23/1998CA2232809A1 Novel compounds
11/23/1998CA2232808A1 Novel compounds
11/23/1998CA2232807A1 Novel compounds
11/23/1998CA2230996A1 Novel compounds
11/23/1998CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/23/1998CA2206047A1 Immunomodulating compositions for the treatment of viral disorders
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/21/1998CA2232811A1 Novel def1
11/19/1998WO1998052047A1 Automated robotic system and method for rapidly screening and identifying useful chemicals in liquid samples
11/19/1998WO1998051798A1 Hgf polypeptides and their use in therapy
11/19/1998WO1998051796A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998WO1998051706A1 Tumor-associated antigen
11/19/1998WO1998051351A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998WO1998051344A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051334A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
11/19/1998WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998WO1998051310A1 A method for the treatment of mental illness in mammals and a composition therefor
11/19/1998WO1998051303A1 Hiv and cancer treatment
1 ... 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 ... 1151